Van Cleef Asset Management,Inc Abbott Laboratories Transaction History

Van Cleef Asset Management,Inc

$876 Million
Q3 2024

A detailed history of Van Cleef Asset Management,Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Van Cleef Asset Management,Inc holds 5,790 shares of ABT stock, worth $688,720. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,790

Previous 5,790 -0.0%

Holding current value

$688,720

Previous $601,000 9.82%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $10,952 - $12,096	-100 Reduced 1.7%	5,790 $658,000
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $9,920 - $12,144	-110 Reduced 1.83%	5,890 $648,000
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $72,984 - $87,569	-764 Reduced 11.3%	6,000 $581,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $74,073 - $82,533	-735 Reduced 9.8%	6,764 $737,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $96 - $114	1 Added 0.01%	7,499 $759,000
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $16,730 - $19,627	176 Added 2.4%	7,498 $823,000
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.01%	7,322 $796,000
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $114,020 - $139,040	-1,000 Reduced 12.02%	7,321 $867,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $73,823 - $90,392	-639 Reduced 7.13%	8,321 $1.17 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $13,117 - $15,441	-124 Reduced 1.37%	8,960 $1.04 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $21,768 - $25,645	-200 Reduced 2.15%	9,084 $1.09 Million
Q4 2020 Feb 17, 2021	BUY	$105.0 - $114.42 $13,545 - $14,760	129 Added 1.41%	9,284 $1.02 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $108,593 - $131,878	-1,185 Reduced 11.46%	9,155 $996,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $149,825 - $219,086	-2,385 Reduced 18.74%	10,340 $816,000
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $6,138 - $6,655	-75 Reduced 0.59%	12,725 $1.07 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $62,246 - $75,256	940 Added 7.93%	12,800 $1.02 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $20,979 - $23,766	320 Added 2.77%	11,860 $858,000
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $43,783 - $52,819	-720 Reduced 5.87%	11,540 $847,000
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $2,302 - $2,541	-40 Reduced 0.33%	12,260 $748,000
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $1,969 - $2,226	-35 Reduced 0.28%	12,300 $737,000
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $14,762 - $15,804	-275 Reduced 2.18%	12,335 $704,000
Q3 2017 Oct 27, 2017	BUY	$48.06 - $53.64 $606,036 - $676,400	12,610	12,610 $673,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Cleef Asset Management,Inc, based on Form 13F filings with the SEC.

News

Stay updated on Van Cleef Asset Management,Inc with notifications on news.

Account

Van Cleef Asset Management,Inc Abbott Laboratories Transaction History